Project description
RNA sequencing and AI for personalised obesity treatment
Obesity, a condition associated with severe diseases, poses a significant risk to human health. The EU-funded EXHEUSVITAL project proposes an evidence-based solution: assisting healthcare professionals to develop personalised treatment plans for individuals with obesity, with the goal of achieving effective weight management. The technology analyses an individual’s gene activation and generates insightful health reports. These reports not only provide information on the person’s current health status but also facilitate continuous patient monitoring. Furthermore, they offer a prognosis of potential pathologies and offer cost-effective therapy solutions. This comprehensive solution combines RNA sequencing and artificial intelligence (AI) technology to enhance recommendations. Additionally, it has the capability to track changes in activated genes over time.
Objective
Exheus VITAL is a unique, evidence-based innovative solution that supports HCPs in providing personalized treatment plans and recommendations to people suffering from obesity to effectively achieve weight management goals. The proprietary technology is based on individual’s gene activation analysis that is converted into insightful health intelligence reports which provide information on the health status of the individual, allow monitoring of patients’ over-time and a prognosis of possible pathologies. Exheus leads to unparalleled health outcomes, benefiting the individual and the society by driving cost-effectiveness of therapy.
Exheus VITAL offers advantages such as:
1.The information provided together by the RNA sequencing and by the Exheus AI technology allows to obtain precise information of the abnormalities in gene expression for each patient. This allow a high level of personalization that can’t be achieved with other methods to provide the best treatment for a given patient.
2.It allows to increase the adherence to the weight loss treatment increasing the effectiveness of the recommendations.
3.It helps HCPs motivate the patient and improve willingness to follow the health recommendations, therefore promoting a change in lifestyle habits sustainable over the time.
4.HCPs (i.e endocrinologist, primary care physicians) can now treat obesity through a clinically validated personalized medicine tool to guide and accompany the patient during its healthy weight loss process.
5.Monitoring the evolution of activated genes over time can be done through repeated tests to determine changes in these parameters.
Exheus VITAL is a fast, effective and attractive tool that helps Health Care Professionals (HCPs) to efficiently support patients with obesity in their weight loss goals. It has been demonstrated that the delivery of the scientifically proven insights (expression levels and changes) and recommendations using a digital method will be effective.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pathology
- natural sciences biological sciences genetics RNA
- medical and health sciences health sciences nutrition obesity
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.3.2 - European innovation ecosystems
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-CSA - HORIZON Coordination and Support Actions
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-EIE-2022-SCALEUP-02
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
08039 Barcelona
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.